pamidronate has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mansouri, M | 1 |
| Mirzaei, SA | 1 |
| Lage, H | 1 |
| Mousavi, SS | 1 |
| Elahian, F | 1 |
| Teronen, O | 1 |
| Heikkilä, P | 1 |
| Konttinen, YT | 1 |
| Laitinen, M | 1 |
| Salo, T | 1 |
| Hanemaaijer, R | 1 |
| Teronen, A | 1 |
| Maisi, P | 1 |
| Sorsa, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I Pilot Trial to Study the Safety and Efficacy of Concomitant Radiotherapy and Zoledronic Acid for the Palliation of Bone Metastases From Breast Cancer, Prostate Cancer and Lung Cancer[NCT00264420] | Phase 1 | 4 participants (Actual) | Interventional | 2005-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for pamidronate and Invasiveness, Neoplasm
| Article | Year |
|---|---|
The cell cycle arrest and the anti-invasive effects of nitrogen-containing bisphosphonates are not mediated by DBF4 in breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tum | 2014 |
MMP inhibition and downregulation by bisphosphonates.
Topics: Alendronate; Antineoplastic Agents; Body Fluids; Collagenases; Diphosphonates; Gene Expression Regul | 1999 |